Clinical Trial Update: Noninvasive Biomarkers for Monitoring Cardiometabolic Risk in Children

View source ↗

Summary

A clinical trial evaluating noninvasive biomarkers to monitor cardiometabolic risk in children with obesity or metabolic syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Obesity

Snippet

Sponsor: West Virginia School of Osteopathic Medicine | Conditions: Obesity, Metabolic Syndrome | Status: TERMINATED